Women in Science: Katherine Vega Stultz on Ocelot’s plans and fostering her ‘CEO sisterhood’ at Bio International
Katherine Vega Stultz is the CEO and president of Ocelot Bio, a clinical-stage biotech company focused on the development of therapeutics to treat complications of end-stage liver disease.